Search
Nuvectis Pharma Inc
NVCTAdd to Watchlist
19.570USD
+0.050+0.26%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
502.49MMarket Cap
LossP/E TTM
Nuvectis Pharma Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.32
-19.21%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its current assets were 31.71M, with a year-on-year change of 70.41.
What are the total assets of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its total assets of Nuvectis Pharma Inc were 31.71M, with a year-on-year change of 70.41.
What are the total liabilities of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its total liabilities of Nuvectis Pharma Inc were 13.30M, with a year-on-year change of 49.49.
What is the total equity of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its total equity of Nuvectis Pharma Inc was 18.41M, with a year-on-year change of 89.57.
What is the net financing of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its net financing of Nuvectis Pharma Inc was 29.11M, with a year-on-year change of 149.79.
What is the Earnings Per Share (EPS) of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.32, with a year-on-year change of -19.21.
What is the Return on Equity (ROE) of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -205.30, with a year-on-year change of -18.39.
What is the Return on Assets (ROA) of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -105.10, with a year-on-year change of -4.53.
What is the operating profit of Nuvectis Pharma Inc?
According to Nuvectis Pharma Inc's FY2025 earnings report, its operating profit was -27.57M, with a year-on-year change of -38.93.